5:59 PM
Mar 21, 2013
 |  BC Extra  |  Top Story

Moderna, AstraZeneca in mRNA deal

AstraZeneca plc (LSE:AZN; NYSE:AZN) partnered with Moderna Therapeutics Inc. (Cambridge, Mass.) to discover, develop and commercialize messenger RNA therapeutics to treat cardiovascular, metabolic and renal diseases, as well as cancer. Under the five-year deal, Moderna will...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >